Mortality and Costs Associated with Wearable Cardioverter-defibrillators after Acute Myocardial Infarction: A Retrospective Cohort Analysis of Medicare Claims Data.

J Innov Card Rhythm Manag · 2019 · PMC7252700 · PMID 32477706

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Conclusion Using a 5% sample of Medicare’s SAFs, this study revealed that WCD use was associated with a nonsignificant trend toward a higher 30-day survival rate and a significant improvement in the one-year survival rate after acute MI.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.